Showing results (581-590 of 595) with videos related to
Sort By:
Pageof 60
Circulation Research|August 20, 2014
Detailed analysis of bone marrow from patients with ischemic heart disease and left ventricular dysfunction: BM CD34, CD11b, and clonogenic capacity as biomarkers for clinical outcomesChristopher R Cogle, Elizabeth Wise, Amy M Meacham, et al.Journal of the American College of Cardiology|September 13, 2023
Comprehensive Management of ANOCA, Part 1-Definition, Patient Population, and Diagnosis: JACC State-of-the-Art ReviewBruce A Samuels, Samit M Shah, R Jay Widmer, et al.Arthritis & Rheumatology (Hoboken, N.J.)|July 23, 2024
Classification Criteria for Axial Disease in Youth With Juvenile SpondyloarthritisPamela F Weiss, Timothy G Brandon, Amita Aggarwal, et al.Circulation Research|February 21, 2015
Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient dataMariann Gyöngyösi, Wojciech Wojakowski, Patricia Lemarchand, et al.The New England Journal of Medicine|November 18, 2024
Routine Spironolactone in Acute Myocardial InfarctionSanjit S Jolly, Marc-André d'Entremont, Bertram Pitt, et al.JACC. Cardiooncology|January 6, 2021
Allogeneic Mesenchymal Cell Therapy in Anthracycline-Induced Cardiomyopathy Heart Failure Patients: The CCTRN SENECA TrialRoberto Bolli, Emerson C Perin, James T Willerson, et al.European Journal of Heart Failure|April 3, 2021
A Phase II study of autologous mesenchymal stromal cells and c-kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT-HF trialRoberto Bolli, Raul D Mitrani, Joshua M Hare, et al.JAMA|March 27, 2012
Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trialEmerson C Perin, James T Willerson, Carl J Pepine, et al.JAMA|November 7, 2012
Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trialJay H Traverse, Timothy D Henry, Carl J Pepine, et al.JAMA|November 16, 2011
Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trialJay H Traverse, Timothy D Henry, Stephen G Ellis, et al.Pageof 60